| Richard D Sue, MD | |
|
2946 E Banner Gateway Dr, Gilbert, AZ 85234 | |
| (480) 256-6444 | |
| (480) 256-3682 |
| Full Name | Richard D Sue |
|---|---|
| Gender | Male |
| Speciality | Critical Care (intensivists) |
| Experience | 30 Years |
| Location | 2946 E Banner Gateway Dr, Gilbert, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053320168 | NPI | - | NPPES |
| 877491 | Medicaid | AZ |
| Facility Name | Location | Facility Type |
|---|---|---|
| St. Joseph's Hospital And Medical Center | Phoenix, AZ | Hospital |
| Banner Gateway Medical Center | Gilbert, AZ | Hospital |
| Honorhealth Deer Valley Medical Center | Phoenix, AZ | Hospital |
| Astria Sunnyside Hospital | Sunnyside, WA | Hospital |
| Banner Boswell Medical Center | Sun city, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Arizona Pulmonary Specialists Ltd | 7618863192 | 45 |
| Rural Physicians Group-pannu Pllc | 0345467486 | 89 |
News Archive
ARYx Therapeutics, Inc., a biopharmaceutical company, announced that a review of the results of the Phase 2b clinical trial, PASCAL, testing the efficacy and safety of ARYx's compound for the treatment of atrial fibrillation, budiodarone, was presented today at the American Heart Association meeting in Orlando, Florida.
Today, at the 2011 American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo, Phadia, the global leader in allergy and autoimmune disease-related diagnostics, demonstrates how ImmunoCAP Molecular Allergy can help improve the diagnosis and management of food allergy.
Parent education programs delivered through pediatric primary care offices increased parent-child play and reading activities critical for child development and school readiness during infancy in at-risk families, according to two concurrent reports in the January issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
Exposure during early pregnancy to some phthalates—man-made chemicals commonly found in household plastics, food and personal care products—can have adverse impacts on developing fetuses, according to a new study led by Dr. Sheela Sathyanarayana, a pediatric environmental health specialist at Seattle Children's Research Institute and associate professor at the University of Washington.
› Verified 5 days ago
| Entity Name | Arizona Pulmonary Specialists Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215986468 PECOS PAC ID: 7618863192 Enrollment ID: O20040223000693 |
News Archive
ARYx Therapeutics, Inc., a biopharmaceutical company, announced that a review of the results of the Phase 2b clinical trial, PASCAL, testing the efficacy and safety of ARYx's compound for the treatment of atrial fibrillation, budiodarone, was presented today at the American Heart Association meeting in Orlando, Florida.
Today, at the 2011 American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo, Phadia, the global leader in allergy and autoimmune disease-related diagnostics, demonstrates how ImmunoCAP Molecular Allergy can help improve the diagnosis and management of food allergy.
Parent education programs delivered through pediatric primary care offices increased parent-child play and reading activities critical for child development and school readiness during infancy in at-risk families, according to two concurrent reports in the January issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
Exposure during early pregnancy to some phthalates—man-made chemicals commonly found in household plastics, food and personal care products—can have adverse impacts on developing fetuses, according to a new study led by Dr. Sheela Sathyanarayana, a pediatric environmental health specialist at Seattle Children's Research Institute and associate professor at the University of Washington.
› Verified 5 days ago
| Entity Name | Sjhmc Physician Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326098005 PECOS PAC ID: 4486646197 Enrollment ID: O20040401001189 |
News Archive
ARYx Therapeutics, Inc., a biopharmaceutical company, announced that a review of the results of the Phase 2b clinical trial, PASCAL, testing the efficacy and safety of ARYx's compound for the treatment of atrial fibrillation, budiodarone, was presented today at the American Heart Association meeting in Orlando, Florida.
Today, at the 2011 American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo, Phadia, the global leader in allergy and autoimmune disease-related diagnostics, demonstrates how ImmunoCAP Molecular Allergy can help improve the diagnosis and management of food allergy.
Parent education programs delivered through pediatric primary care offices increased parent-child play and reading activities critical for child development and school readiness during infancy in at-risk families, according to two concurrent reports in the January issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
Exposure during early pregnancy to some phthalates—man-made chemicals commonly found in household plastics, food and personal care products—can have adverse impacts on developing fetuses, according to a new study led by Dr. Sheela Sathyanarayana, a pediatric environmental health specialist at Seattle Children's Research Institute and associate professor at the University of Washington.
› Verified 5 days ago
| Entity Name | St. Joseph's Hospital And Medical Center C/o Dignity Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255382412 PECOS PAC ID: 6709863178 Enrollment ID: O20040702000601 |
News Archive
ARYx Therapeutics, Inc., a biopharmaceutical company, announced that a review of the results of the Phase 2b clinical trial, PASCAL, testing the efficacy and safety of ARYx's compound for the treatment of atrial fibrillation, budiodarone, was presented today at the American Heart Association meeting in Orlando, Florida.
Today, at the 2011 American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo, Phadia, the global leader in allergy and autoimmune disease-related diagnostics, demonstrates how ImmunoCAP Molecular Allergy can help improve the diagnosis and management of food allergy.
Parent education programs delivered through pediatric primary care offices increased parent-child play and reading activities critical for child development and school readiness during infancy in at-risk families, according to two concurrent reports in the January issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
Exposure during early pregnancy to some phthalates—man-made chemicals commonly found in household plastics, food and personal care products—can have adverse impacts on developing fetuses, according to a new study led by Dr. Sheela Sathyanarayana, a pediatric environmental health specialist at Seattle Children's Research Institute and associate professor at the University of Washington.
› Verified 5 days ago
| Entity Name | Banner Cancer Center Specialists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518253152 PECOS PAC ID: 6103097779 Enrollment ID: O20110913000224 |
News Archive
ARYx Therapeutics, Inc., a biopharmaceutical company, announced that a review of the results of the Phase 2b clinical trial, PASCAL, testing the efficacy and safety of ARYx's compound for the treatment of atrial fibrillation, budiodarone, was presented today at the American Heart Association meeting in Orlando, Florida.
Today, at the 2011 American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo, Phadia, the global leader in allergy and autoimmune disease-related diagnostics, demonstrates how ImmunoCAP Molecular Allergy can help improve the diagnosis and management of food allergy.
Parent education programs delivered through pediatric primary care offices increased parent-child play and reading activities critical for child development and school readiness during infancy in at-risk families, according to two concurrent reports in the January issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
Exposure during early pregnancy to some phthalates—man-made chemicals commonly found in household plastics, food and personal care products—can have adverse impacts on developing fetuses, according to a new study led by Dr. Sheela Sathyanarayana, a pediatric environmental health specialist at Seattle Children's Research Institute and associate professor at the University of Washington.
› Verified 5 days ago
| Entity Name | Banner Hospital Based Physicians Arizona Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275889891 PECOS PAC ID: 3274782487 Enrollment ID: O20121003000752 |
News Archive
ARYx Therapeutics, Inc., a biopharmaceutical company, announced that a review of the results of the Phase 2b clinical trial, PASCAL, testing the efficacy and safety of ARYx's compound for the treatment of atrial fibrillation, budiodarone, was presented today at the American Heart Association meeting in Orlando, Florida.
Today, at the 2011 American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo, Phadia, the global leader in allergy and autoimmune disease-related diagnostics, demonstrates how ImmunoCAP Molecular Allergy can help improve the diagnosis and management of food allergy.
Parent education programs delivered through pediatric primary care offices increased parent-child play and reading activities critical for child development and school readiness during infancy in at-risk families, according to two concurrent reports in the January issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
Exposure during early pregnancy to some phthalates—man-made chemicals commonly found in household plastics, food and personal care products—can have adverse impacts on developing fetuses, according to a new study led by Dr. Sheela Sathyanarayana, a pediatric environmental health specialist at Seattle Children's Research Institute and associate professor at the University of Washington.
› Verified 5 days ago
| Entity Name | Banner - University Physician Specialists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437529245 PECOS PAC ID: 5991008054 Enrollment ID: O20160122001476 |
News Archive
ARYx Therapeutics, Inc., a biopharmaceutical company, announced that a review of the results of the Phase 2b clinical trial, PASCAL, testing the efficacy and safety of ARYx's compound for the treatment of atrial fibrillation, budiodarone, was presented today at the American Heart Association meeting in Orlando, Florida.
Today, at the 2011 American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo, Phadia, the global leader in allergy and autoimmune disease-related diagnostics, demonstrates how ImmunoCAP Molecular Allergy can help improve the diagnosis and management of food allergy.
Parent education programs delivered through pediatric primary care offices increased parent-child play and reading activities critical for child development and school readiness during infancy in at-risk families, according to two concurrent reports in the January issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
Exposure during early pregnancy to some phthalates—man-made chemicals commonly found in household plastics, food and personal care products—can have adverse impacts on developing fetuses, according to a new study led by Dr. Sheela Sathyanarayana, a pediatric environmental health specialist at Seattle Children's Research Institute and associate professor at the University of Washington.
› Verified 5 days ago
| Entity Name | Banner - University Super Specialists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740650555 PECOS PAC ID: 1850695255 Enrollment ID: O20160204002443 |
News Archive
ARYx Therapeutics, Inc., a biopharmaceutical company, announced that a review of the results of the Phase 2b clinical trial, PASCAL, testing the efficacy and safety of ARYx's compound for the treatment of atrial fibrillation, budiodarone, was presented today at the American Heart Association meeting in Orlando, Florida.
Today, at the 2011 American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo, Phadia, the global leader in allergy and autoimmune disease-related diagnostics, demonstrates how ImmunoCAP Molecular Allergy can help improve the diagnosis and management of food allergy.
Parent education programs delivered through pediatric primary care offices increased parent-child play and reading activities critical for child development and school readiness during infancy in at-risk families, according to two concurrent reports in the January issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
Exposure during early pregnancy to some phthalates—man-made chemicals commonly found in household plastics, food and personal care products—can have adverse impacts on developing fetuses, according to a new study led by Dr. Sheela Sathyanarayana, a pediatric environmental health specialist at Seattle Children's Research Institute and associate professor at the University of Washington.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Richard D Sue, MD 2946 E Banner Gateway Dr, Gilbert, AZ 85234 Ph: (480) 256-6444 | Richard D Sue, MD 2946 E Banner Gateway Dr, Gilbert, AZ 85234 Ph: (480) 256-6444 |
News Archive
ARYx Therapeutics, Inc., a biopharmaceutical company, announced that a review of the results of the Phase 2b clinical trial, PASCAL, testing the efficacy and safety of ARYx's compound for the treatment of atrial fibrillation, budiodarone, was presented today at the American Heart Association meeting in Orlando, Florida.
Today, at the 2011 American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo, Phadia, the global leader in allergy and autoimmune disease-related diagnostics, demonstrates how ImmunoCAP Molecular Allergy can help improve the diagnosis and management of food allergy.
Parent education programs delivered through pediatric primary care offices increased parent-child play and reading activities critical for child development and school readiness during infancy in at-risk families, according to two concurrent reports in the January issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
Exposure during early pregnancy to some phthalates—man-made chemicals commonly found in household plastics, food and personal care products—can have adverse impacts on developing fetuses, according to a new study led by Dr. Sheela Sathyanarayana, a pediatric environmental health specialist at Seattle Children's Research Institute and associate professor at the University of Washington.
› Verified 5 days ago
Sandhyaben P Patel, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1900 N Higley Rd, Gilbert, AZ 85234 Phone: 480-543-2134 Fax: 480-512-6089 | |
Dr. Shivakumar Vignesh, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2946 E Banner Gateway Dr., Suite 400, Gilbert, AZ 85234 Phone: 480-256-3332 Fax: 813-449-8028 | |
Dr. Noreen Catherine Ruane, D.O. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 3555 S Val Vista Dr, Gilbert, AZ 85297 Phone: 602-933-0777 Fax: 602-933-0755 | |
Dr. Ala Eddin Samir Sagar, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2940 E Banner Gateway Drive, Gilbert, AZ 85234 Phone: 480-256-6444 Fax: 480-256-3682 | |
Theresa Ong Liu Dumlao, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2946 E Banner Gateway Dr, Suite 450, Gilbert, AZ 85234 Phone: 480-256-6444 Fax: 480-256-4683 | |
Dr. Zachary Phillip Yeung, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2946 E Banner Gateway Dr, Gilbert, AZ 85234 Phone: 480-245-6444 Fax: 480-256-4623 |